Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mecasermin - Ipsen

Next Previous
X
Search
Drug Profile

Mecasermin - Ipsen

Alternative Names: FK 780; IGF-1; Increlex; Insulin-like growth factor-1; rhIGF-I; Somatomedin-1

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Genentech
  • Developer Ipsen; Ipsen Biopharmaceuticals; Tercica
  • Class Antihyperglycaemics; Growth factors; Peptides
  • Mechanism of Action Insulin-like growth factor I stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Short stature
  • New Molecular Entity No

Highest Development Phases

  • Marketed Short stature
  • Discontinued Diabetes mellitus

Most Recent Events

  • 16 Mar 2021 Launched for Short stature (In adolescents, In children) in Canada (SC)
  • 17 Dec 2020 Registered for Short stature (In adolescents, In children) in Canada (SC)
  • 22 Nov 2019 Registered for Short stature (In adolescents, In children) in Australia (SC)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top